The FDA approved Tonmya, a first-in-class, non-opioid, once-daily bedtime analgesic, for the treatment of fibromyalgia in ...

Diet-driven metabolites had close associations with various blood-based biomarkers indicative of Alzheimer’s disease ...

Summer has arrived with a molten thud here on America’s North Coast. It’s time to retire to my porch and recline under an ...

In this video from the American Society of Retina Specialists annual meeting, Diana V. Do, MD, FASRS, discusses a post hoc analysis of the OAKS and DERBY studies of pegcetacoplan in bilateral ...

In this Healio video, Nancy A. Hodgson, PhD, RN, FAAN, FGSA, discusses her presentation from the Alzheimer’s Association International Conference focusing on the impact of caregiving, common features ...

Prenatal exposure to acetaminophen may increase the risk for neurodevelopmental disorders in youth, according to new data from a systematic review published in BMC Environmental Health.“Overall, the e ...

The FDA approved the adenoviral vector-based immunotherapy, zopapogene imadenovec-drba, for treatment of certain patients ...

The Infectious Diseases Society of America has begun updating its clinical practice guidelines for managing histoplasmosis ...

HHS Secretary Robert F. Kennedy Jr.’s decision to dismiss all 17 members of the CDC Advisory Committee on Immunization ...

Ustekinumab and vedolizumab both demonstrated safety and efficacy in treating Crohn’s disease of the pouch, according to ...

Laser therapy has been the subject of many legal cases brought against clinicians, according to a study published in the ...

Rising health care costs and federal policy changes are driving up premium rates for the growing number of Americans covered by the Affordable Care Act, which could be detrimental for these ...